Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Participants in the Q4 group were more likely to have kidney stones, be older, male, Non-Hispanic Black, have less than a high school education, be widowed, have a lower PIR, a higher BMI, higher creatinine levels, higher uric acid levels, lower serum vitamin D levels, lower daily calcium intake, lower daily vitamin D intake, lower daily dietary fiber intake, lower daily moisture intake, and lower daily alcohol intake.

Source: 3.1. Participants and demographic characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Ultimately, 34,122 participants were included in the final analysis.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Positive association between serum calcium-phosphorus ratio and kidney stone prevalence: Analysis of NHANES data (2007 to 2020)

Study design awaiting verification · Medicine · 2026

Original publication title

Positive association between serum calcium-phosphorus ratio and kidney stone prevalence: Analysis of NHANES data (2007 to 2020)

Jian Qin; Xia Liu; Miao Yu

Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, Inc.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study, based on large-scale population data analysis, found a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones, and this association with no evidence of nonlinearity. The balance of calcium-phosphorus metabolism is crucial for the prevention of kidney stone formation, and an elevated serum calcium-phosphorus ratio may be an independent risk factor for kidney stone formation. Future research should further explore the potential role of calcium-phosphorus metabolic interventions and the serum calcium-phosphorus ratio as a risk marker for kidney stones.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Kidney stones are a common urological disease worldwide, with an increasing incidence trend year by year.[1,2] The causes of kidney stone formation are complex, involving genetic, environmental, dietary, and other factors.[3,4] In recent years, increasing attention has been paid to the relationship between mineral balance in the blood and kidney stone formation, particularly the role of minerals such as calcium and phosphorus.[5,6] However, while the independent effects of calcium and phosphorus have been widely studied, the potential role of the serum calcium-phosphorus ratio as a risk factor remains poorly understood.

Calcium-phosphorus homeostasis is not only a key indicator of bone metabolism but also plays a crucial role in maintaining overall mineral balance, regulating parathyroid function, and supporting cardiovascular health.[7,8] Calcium is a major component of bones and teeth and is involved in vital physiological functions such as nerve conduction, muscle contraction, and blood clotting.[9,10] Phosphorus, on the other hand, is essential for cellular energy metabolism, maintaining cell membrane integrity, and nucleic acid synthesis.[11,12] The balance between calcium and phosphorus is critical for sustaining normal physiological functions.

When this balance is disrupted, it can lead to a range of health issues, such as osteoporosis, parathyroid dysfunction, and cardiovascular disease.[7,8] Studies have suggested that disturbances in calcium-phosphorus metabolism may be associated with various metabolic diseases, particularly in the formation of kidney stones, where calcium-phosphorus metabolic imbalances may play a key role.[13,14] However, despite numerous studies on the independent effects of calcium and phosphorus, systematic research on the direct association between the calcium-phosphorus ratio and kidney stone prevalence is still lacking, especially in studies based on large-scale population samples.

Rather than isolated alterations in serum calcium or phosphorus, their relative balance may better reflect systemic mineral homeostasis. The calcium-phosphorus ratio has been proposed as a simple and inexpensive composite marker for identifying disorders of calcium-phosphorus metabolism, particularly in the screening of primary hyperparathyroidism.[15,16] Recent population-based research has further applied the calcium-phosphorus ratio in epidemiological analyses of metabolic diseases, suggesting that it may capture subtle mineral imbalance not fully reflected by either mineral alone.[17] However, its potential relevance to nephrolithiasis has not been systematically investigated in large-scale population studies.

This study, based on data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2020, aims to systematically evaluate the association between the serum calcium-phosphorus ratio and the prevalence of kidney stones. By utilizing this large-scale, nationally representative population data, we explore whether the serum calcium-phosphorus ratio serves as an independent risk factor for kidney stone formation, while controlling for other potential confounding factors. This study not only fills gaps in the existing literature but also provides new insights into the prevention and management of kidney stones.

The central objective of this study was to determine whether a significant positive association exists between the serum calcium-phosphorus ratio and the prevalence of kidney stones. If confirmed, this finding may identify a new risk marker and offer a scientific basis for kidney stone risk assessment and intervention strategies, as well as provide new perspectives on its pathogenesis and preventive measures.

Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction

Study methods

What methods does the paper describe?

2.1. Data source

The data used in this study were sourced from NHANES. NHANES is an ongoing, nationally representative population survey led by the Centers for Disease Control and Prevention (CDC), aimed at assessing the health and nutritional status of the adult and child in the United States. The survey employs a stratified, multistage probability sampling design to ensure that the findings are representative. For this study, data from NHANES between 2007 and 2020 were selected. NHANES data collection includes 3 major components: comprehensive questionnaires, clinical examinations, and laboratory tests.

To ensure the representativeness and reliability of the data, we used the sampling weights provided by NHANES to adjust for differences across survey years and population groups. The data analysis utilized merged multi-cycle weights to ensure that the results reflect the overall adult population of the United States. All data were obtained from the publicly available NHANES database, and no personally identifiable information was involved, thus no additional ethical approval was required. To ensure the accuracy and broad applicability of the data, the NHANES data collection and survey design followed strict standardization protocols, and detailed descriptions of all variable definitions and methodologies are available on the NHANES website.[18,19]

2.2. Study population

The data for this study were obtained from participants in NHANES from 2007 to 2020, with an initial sample of 66,148 individuals. During the screening process, individuals younger than 20 years of age (n = 27,715), those with missing data on kidney stones (n = 104), and those missing data on the serum calcium-phosphorus ratio (n = 4207) were excluded. Ultimately, 34,122 participants were included in the final analysis. Figure 1 presents the participant selection flowchart.

Figure 1.

Flowchart of the participant selection process. NHANES = National Health and Nutrition Examination Survey.

Figure image at the original source: open the original paper. This file is not included in this text import.

2.3. Measurement of serum calcium, serum phosphorus, and calculation of the ratio

This study utilized laboratory data provided by NHANES, with serum calcium and serum phosphorus measured using the automated analysis systems LX20 and DxC800, respectively. Serum calcium measurement: Serum calcium was measured using the ion-selective electrode (ISE) method. The calcium ion concentration was calculated using the Nernst equation, based on the potential change generated by the binding of calcium ions to the ionophore on the electrode surface. Serum phosphorus measurement: serum phosphorus was measured using a timed-rate method. In this process, phosphorus reacts with ammonium molybdate in an acidic solution to form a colored phosphomolybdate complex.

The change in absorbance, measured at a wavelength of 365 nm, is directly proportional to the phosphorus concentration. Calculation of the calcium-phosphorus ratio: the calcium-phosphorus ratio was calculated by dividing the serum calcium concentration (mg/dL) by the serum phosphorus concentration (mg/dL). This ratio was used to evaluate the association with kidney stone prevalence.

2.4. Definition of kidney stones

In this study, the definition of kidney stones was based on participants’ self-reports from the NHANES health questionnaire. Participants were asked whether they had ever been diagnosed with kidney stones by a healthcare professional. The specific question was: “Has a doctor or other health professional ever told you that you had kidney stones?” Individuals who answered “Yes” were identified as having a history of kidney stones and were classified into the kidney stone group.

2.5. Covariates

In the analysis of the association between the serum calcium-phosphorus ratio and the prevalence of kidney stones, several covariates that could potentially influence the results were adjusted for. These covariates covered demographic characteristics, health status, dietary factors, and lifestyle factors, including: age, gender, race/ethnicity (Mexican American, Other Hispanic, Non-Hispanic White, Non-Hispanic Black, and Other Race), education level (less than high school, high school or equivalent, college or above), marital status (married, widowed, divorced, separated, never married, living with a partner), poverty-to-income ratio (PIR), body mass index (BMI), serum creatinine levels, uric acid levels, serum vitamin D levels, daily calcium intake, daily phosphorus intake, daily vitamin D intake, daily dietary fiber intake, daily moisture intake, daily alcohol intake, physical activity (recommended activity and insufficient activity),[20] hypertension (yes/no), diabetes (yes/no), smoking status (never smoked, former smoker, current smoker),[21] and depression status (yes/no).

All these covariates were included in the multivariable analysis models to control for their potential influence on the association between the serum calcium-phosphorus ratio and the prevalence of kidney stones.

2.6. Statistical analyses

Calcium-phosphorus ratio levels were divided into 4 quartiles: Q1, Q2, Q3, and Q4. Missing values were imputed as follows: mode imputation for categorical variables, mean imputation for normally distributed continuous variables, and median imputation for skewed continuous variables. Categorical variables were presented as percentages and compared using a weighted chi-square test. For normally distributed continuous variables, results were expressed as mean ± standard deviation, and group comparisons were made using a weighted t-test. For non-normally distributed continuous variables, median and interquartile range (IQR) were used for description, and comparisons were conducted using a weighted Kruskal: Wallis test.

To explore the association between calcium-phosphorus ratio levels and the prevalence of kidney stones, 3 multivariable logistic regression models were constructed. Model 1 was unadjusted for any covariates. Model 2 was based on model 1, with adjustments for age, gender, race, education level, marital status, PIR, BMI, serum creatinine, uric acid, and serum vitamin D levels. Model 3 was adjusted for all covariates. Restricted cubic spline (RCS) analysis was used to explore the nonlinear association between the calcium-phosphorus ratio and the prevalence of kidney stones.

Subgroup analyses were conducted to further investigate the association between calcium-phosphorus ratio and kidney stone prevalence in different populations. To examine the potential influence of different covariates on the association between calcium-phosphorus ratio and the prevalence of kidney stones, interaction analyses were performed to test the interactions between calcium-phosphorus ratio and key covariates. All statistical analyses were performed using R software (version 4.2.2; R Foundation for Statistical Computing, Vienna, Austria) and Free Statistics software (version 1.9). A 2-sided P-value of <.05 was considered statistically significant.

Source: 2. Materials and methods Source: 2. Materials and methods Source: 2. Materials and methods Source: 2. Materials and methods Source: 2. Materials and methods Source: 2. Materials and methods

Participants and demographic characteristics

Results: Participants and demographic characteristics

This study analyzed NHANES data from 2007 to 2020, including 34,122 eligible participants. Of these, 3207 participants were diagnosed with kidney stones. Serum calcium-phosphorus ratio levels were categorized into 4 groups: Q1 (0.74 to 2.31) with 8423 participants, Q2 (2.32 to 2.54) with 8469 participants, Q3 (2.55 to 2.81) with 8622 participants, and Q4 (2.82 to 10.10) with 8608 participants. Participants in the Q4 group were more likely to have kidney stones, be older, male, Non-Hispanic Black, have less than a high school education, be widowed, have a lower PIR, a higher BMI, higher creatinine levels, higher uric acid levels, lower serum vitamin D levels, lower daily calcium intake, lower daily vitamin D intake, lower daily dietary fiber intake, lower daily moisture intake, and lower daily alcohol intake.

Additionally, they were more likely to have hypertension, diabetes, be former smokers, and not have depression (Table 1).

Table 1

Baseline characteristics of the study participants.

Serum calcium-phosphorus ratio
Q1 (0.74 to 2.31)Q2 (2.32 to 2.54)Q3 (2.55 to 2.81)Q4(2.82 to 10.10)
VariablesTotal (n = 34,122)(n = 8423)(n = 8469)(n = 8622)(n = 8608)P-value
Kidney stone, n (%)<.001
 No30,915 (90.6)7718 (91.6)7736 (91.3)7824 (90.7)7637 (88.7)
 Yes3207 (9.4)705 (8.4)733 (8.7)798 (9.3)971 (11.3)
Age (yr), Median (IQR)50.0 (35.0, 64.0)48.0 (32.0, 62.0)49.0 (34.0, 63.0)50.0 (35.0, 64.0)51.0 (37.0, 65.0)<.001
Gender, n (%)<.001
 Male16,551 (48.5)3280 (38.9)3673 (43.4)4353 (50.5)5245 (60.9)
 Female17,571 (51.5)5143 (61.1)4796 (56.6)4269 (49.5)3363 (39.1)
Race, n (%)<.001
 Mexican American5040 (14.8)1239 (14.7)1272 (15)1276 (14.8)1253 (14.6)
 Other Hispanic3648 (10.7)896 (10.6)961 (11.3)902 (10.5)889 (10.3)
 Non-Hispanic White13,913 (40.8)3618 (43)3429 (40.5)3465 (40.2)3401 (39.5)
 Non-Hispanic Black7301 (21.4)1584 (18.8)1714 (20.2)1902 (22.1)2101 (24.4)
 Other Race4220 (12.4)1086 (12.9)1093 (12.9)1077 (12.5)964 (11.2)
Education, n (%).005
 Less than high school8172 (23.9)1977 (23.5)1942 (22.9)2031 (23.6)2222 (25.8)
 High school or equivalent7788 (22.8)1878 (22.3)1918 (22.6)1916 (22.2)2076 (24.1)
 College or above18,162 (53.2)4568 (54.2)4609 (54.4)4675 (54.2)4310 (50.1)
Marital status, n (%).015
 Married18,136 (53.2)4268 (50.7)4429 (52.3)4746 (55)4693 (54.5)
 Widowed3871 (11.3)916 (10.9)956 (11.3)972 (11.3)1027 (11.9)
 Divorced4362 (12.8)1039 (12.3)1121 (13.2)1072 (12.4)1130 (13.1)
 Separated891 (2.6)247 (2.9)227 (2.7)215 (2.5)202 (2.3)
 Never married4785 (14.0)1374 (16.3)1207 (14.3)1096 (12.7)1108 (12.9)
 Living with partner2077 (6.1)579 (6.9)529 (6.2)521 (6)448 (5.2)
PIR, Median (IQR)2.4 (1.2, 3.8)2.3 (1.1, 3.7)2.5 (1.2, 3.9)2.5 (1.2, 3.9)2.3 (1.2, 3.7).021
BMI (kg/m2), Median (IQR)28.3 (24.5, 32.8)28.0 (24.0, 32.5)28.2 (24.3, 32.5)28.3 (24.5, 32.8)28.7 (25.1, 33.1)<.001
Creatinine (mg/dL), Median (IQR)0.8 (0.7, 1.0)0.8 (0.7, 1.0)0.8 (0.7, 1.0)0.8 (0.7, 1.0)0.9 (0.7, 1.0)<.001
Uric acid (mg/dL), Median (IQR)5.3 (4.4, 6.3)5.2 (4.3, 6.2)5.2 (4.3, 6.2)5.3 (4.4, 6.4)5.5 (4.6, 6.5)<.001
Serum vitamin D (nmol/L), Median (IQR)64.1 (50.5, 72.8)64.1 (49.3, 75.6)64.1 (50.3, 73.2)64.1 (51.3, 72.7)64.1 (50.8, 69.2).027
Daily calcium intake (mg), Median (IQR)853.0 (586.5, 1100.0)878.5 (606.5, 1126.2)859.5 (592.0, 1095.5)841.2 (583.1, 1095.0)831.0 (563.9, 1085.8).019
Daily phosphorus intake (mg), Median (IQR)1275.5 (948.5, 1569.0)1281.0 (958.0, 1581.8)1276.0 (954.5, 1556.5)1273.0 (945.0, 1566.4)1271.5 (937.0, 1570.6).596
Daily vitamin D intake (mcg), Median (IQR)3.7 (1.9, 5.7)3.9 (2.0, 5.9)3.8 (1.9, 5.7)3.6 (1.9, 5.6)3.5 (1.7, 5.4).002
Daily dietary fiber intake (g), Median (IQR)15.7 (10.6, 20.5)15.7 (10.8, 20.3)15.8 (10.7, 20.8)15.7 (10.8, 20.5)15.4 (10.3, 20.4).693
Daily moisture intake (g), Median (IQR)2639.9 (1941.6, 3289.8)2672.4 (1957.0, 3328.9)2633.9 (1952.9, 3296.7)2635.7 (1933.3, 3254.4)2619.6 (1929.6, 3286.4).552
Daily alcohol intake (g), Median (IQR)0.0 (0.0, 8.3)0.0 (0.0, 8.3)0.0 (0.0, 8.3)0.0 (0.0, 8.3)0.0 (0.0, 8.3).075
Physical activity, n (%).259
 Insufficient activity2510 (7.4)580 (6.9)639 (7.5)632 (7.3)659 (7.7)
 Recommended activity31,612 (92.6)7843 (93.1)7830 (92.5)7990 (92.7)7949 (92.3)
Hypertension, n (%)<.001
 No21,677 (63.5)5526 (65.6)5493 (64.9)5451 (63.2)5207 (60.5)
 Yes12,445 (36.5)2897 (34.4)2976 (35.1)3171 (36.8)3401 (39.5)
Diabetes, n (%).156
 No29,559 (86.6)7331 (87)7380 (87.1)7468 (86.6)7380 (85.7)
 Yes4563 (13.4)1092 (13)1089 (12.9)1154 (13.4)1228 (14.3)
Smoking, n (%)<.001
 Never19,145 (56.1)4805 (57)4895 (57.8)4873 (56.5)4572 (53.1)
 Former8158 (23.9)1801 (21.4)1920 (22.7)2121 (24.6)2316 (26.9)
 Now6819 (20.0)1817 (21.6)1654 (19.5)1628 (18.9)1720 (20)
Depression, n (%).018
 No31,392 (92.0)7686 (91.3)7780 (91.9)7996 (92.7)7930 (92.1)
 Yes2730 (8.0)737 (8.7)689 (8.1)626 (7.3)678 (7.9)

BMI = body mass index, g = gram, IQR = interquartile range, PIR = poverty-to-income ratio.

Source: 3.1. Participants and demographic characteristics Source: 3.1. Participants and demographic characteristics

The association between serum calcium-phosphorus ratio levels and the prevalence of kidney stones

Results: The association between serum calcium-phosphorus ratio levels and the prevalence of kidney stones

When serum calcium-phosphorus ratio was analyzed as a continuous variable, model 1, which did not adjust for covariates, showed a significant positive association between serum calcium-phosphorus ratio and the prevalence of kidney stones (OR: 1.40, 95% CI: 1.24 to 1.58; P < .001). This association remained significant in both model 2, and model 3 after adjusting for covariates. As serum calcium-phosphorus ratio levels increased, the association became more pronounced, particularly in model 3, where the OR for the fourth quartile was significantly higher than that for the first quartile (OR: 1.32, 95% CI: 1.14 to 1.53).

The trend analysis indicated a significant positive association between serum calcium-phosphorus ratio and the prevalence of kidney stones (P for trend < .001; Table 2). After accounting for all potential confounders, the RCS analysis confirmed a significant positive association between serum calcium-phosphorus ratio and the prevalence of kidney stones, with no evidence of nonlinearity (nonlinearity: P = .558; Fig. 2).

Table 2

The associations between serum calcium-phosphorus ratio levels and the prevalence of kidney stones.

Model 1Model 2Model 3
OR (95% CI)P-valueOR (95% CI)P-valueOR (95% CI)P-value
Continuous1.40 (1.24, 1.58)<.0011.31 (1.15, 1.48)<.0011.29 (1.14, 1.45)<.001
Quartile
 Q1ReferenceReferenceReference
 Q21.13 (0.96, 1.33).1371.11 (0.95, 1.31).1901.12 (0.95, 1.31).178
 Q31.16 (1.02, 1.32).0271.11 (0.97, 1.27).1181.11 (0.97, 1.27).122
 Q41.48 (1.28, 1.72)<.0011.34 (1.16, 1.56)<.0011.32 (1.14, 1.53)<.001
P for trend<.001<.001<.001

Model 1: no covariates adjusted.

Model 2: adjusted for age, gender, race, education, marital status, PIR, BMI, creatinine, uric acid, serum vitamin D.

Model 3: further adjusted for daily calcium intake, daily phosphorus intake, daily vitamin D intake, daily dietary fiber intake, daily moisture intake, daily alcohol intake, physical activity, hypertension, diabetes, smoking, and depression based on model 2.

CI = confidence interval, OR = odds ratio.

Figure 2.

Restricted cubic spline analysis of the association between serum calcium-phosphorus ratio and the prevalence of kidney stones. The reference point (median) is 2.54. CI = confidence interval, OR = odds ratio.

Figure image at the original source: open the original paper. This file is not included in this text import.
Source: 3.2. The association between serum calcium-phosphorus ratio levels and the prevalence of kidney stones Source: 3.2. The association between serum calcium-phosphorus ratio levels and the prevalence of kidney stones Source: 3.2. The association between serum calcium-phosphorus ratio levels and the prevalence of kidney stones

Results: Subgroup analyses and interaction effects

Subgroup and interaction analyses were conducted based on age, gender, race, education level, marital status, daily moisture intake, and physical activity. The subgroup analysis revealed that the positive association remained consistent across multiple subgroups, with no significant interactions observed (Fig. 3).

Figure 3.

Subgroup analysis and interaction effects for the association between serum calcium-phosphorus ratio and the prevalence of kidney stones. CI = confidence interval, OR = odds ratio.

Figure image at the original source: open the original paper. This file is not included in this text import.
Source: 3.3. Subgroup analyses and interaction effects Source: 3.3. Subgroup analyses and interaction effects

Results: Sensitivity analysis results

In the sensitivity analysis, different data processing methods were used to validate the robustness of the results: using the complete dataset (without imputation) and adjusting for multiple covariates, the results showed a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones (OR: 1.41, 95% CI: 1.16 to 1.71, P < .001); after excluding the top and bottom 2.5% extreme values and adjusting for multiple covariates, the results also showed a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones (OR: 1.34, 95% CI: 1.16 to 1.54, P < .001; Table 3).

Table 3

Sensitivity analysis.

Model 1Model 2Model 3
Sensitivity analysis methodsOR (95% CI)P-valueOR (95% CI)P-valueOR (95% CI)P-value
The complete dataset, without imputation1.55 (1.28, 1.87)<.0011.41 (1.17, 1.70)<.0011.41 (1.16, 1.71)<.001
After excluding the top and bottom 2.5% extreme values1.51 (1.30, 1.75)<.0011.35 (1.17, 1.56)<.0011.34 (1.16, 1.54)<.001

Model 1: no covariates adjusted.

Model 2: adjusted for age, gender, race, education, marital status, PIR, BMI, creatinine, uric acid, serum vitamin D.

Model 3: further adjusted for daily calcium intake, daily phosphorus intake, daily vitamin D intake, daily dietary fiber intake, daily moisture intake, daily alcohol intake, physical activity, hypertension, diabetes, smoking, and depression based on model 2.

CI = confidence interval, OR = odds ratio.

Source: 3.4. Sensitivity analysis results Source: 3.4. Sensitivity analysis results

Discussion

In this study, we analyzed the association between the serum calcium-phosphorus ratio and the prevalence of kidney stones based on data from NHANES (2007 to 2020). The results indicated a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones. Multivariable logistic regression analysis showed that this association remained significant even after adjusting for various potential confounding factors. Specifically, individuals in the highest quartile (Q4) of the serum calcium-phosphorus ratio had a significantly higher prevalence of kidney stones compared to those in the lowest quartile (Q1).

RCS analysis further confirmed that this positive association was linear, with no evidence of nonlinearity. The serum calcium-phosphorus ratio and the serum phosphorus-to-calcium ratio are mathematically reciprocal transformations and therefore convey identical statistical information. Accordingly, the choice between them does not affect statistical inference. We selected the serum calcium-phosphorus ratio because it more directly reflects the established role of calcium as the principal component of most kidney stones and enhances clinical interpretability. Existing research suggests that disturbances in calcium-phosphorus metabolism are closely related to the prevalence of kidney stones.

Taylor et al’s study included 356 men with newly diagnosed symptomatic kidney stones and 712 healthy men as a control group. Using a prospective nested case-control study design, they analyzed the association between plasma calcium-phosphorus regulatory hormones and the prevalence of kidney stones. The results indicated that calcium-phosphorus metabolic disturbances may be a key factor in the formation of kidney stones.[13] In a study by Zhang et al, 24 patients with calcium stone and 21 non-stone controls were included, with a focus on biomarkers related to calcium-phosphorus metabolism.

The study compared the differences in calcium-phosphorus regulatory proteins between the 2 groups and found that the excretion of exosomes carrying calcium-phosphorus regulatory proteins was significantly reduced in the urine of calcium stone patients, further suggesting that abnormalities in calcium-phosphorus metabolism may play an important role in the formation of kidney stones.[22]

Beyond the independent effects of calcium and phosphorus, the serum calcium-phosphorus ratio may serve as a more integrated marker of systemic mineral homeostasis. An altered ratio reflects a relative predominance of one mineral over the other and may indicate dysregulation within the tightly regulated calcium: phosphorus: PTH: vitamin D axis.[23] Such systemic imbalance may influence renal mineral handling and alter urinary supersaturation dynamics, thereby modifying crystal formation risk.[24,25] Therefore, the positive association observed between the serum calcium-phosphorus ratio and kidney stone prevalence may reflect broader disturbances in mineral regulation rather than the isolated effect of either calcium or phosphorus alone.

Disturbances in calcium-phosphorus metabolism are closely related to the formation of kidney stones. Calcium and phosphorus are key minerals for maintaining bone health and various physiological functions, and their metabolic imbalance in the kidneys may directly contribute to kidney stone formation. First, an elevated calcium-phosphorus ratio may lead to increased saturation of calcium and phosphorus in the urine, which in turn promotes the formation of calcium oxalate or calcium phosphate crystals. Once these crystals deposit in the renal tubules, they can become the nucleus for kidney stone formation.[26-28] Second, the regulation of calcium-phosphorus metabolism involves several key molecules and hormones, among which fibroblast growth factor 23 (FGF23) plays a central role in regulating serum phosphorus levels.

FGF23 inhibits the synthesis of 1,25-dihydroxyvitamin D, reduces the intestinal absorption of phosphorus, and increases renal phosphorus excretion. When serum phosphorus levels rise, FGF23 secretion increases, leading to greater phosphorus excretion and disruption of the calcium-phosphorus balance. This process, accompanied by reduced calcium absorption, may result in increased urinary calcium excretion, thereby promoting the formation of kidney stones.[13,29-31] The calcium-sensing receptor (CaSR) is another important molecule in the regulation of calcium-phosphorus metabolism in the kidneys. When serum calcium levels are elevated, CaSR is activated, reducing calcium reabsorption and increasing urinary calcium excretion.

Although this mechanism helps maintain serum calcium levels in the short term, prolonged urinary calcium excretion may promote kidney stone formation.[32-34] Furthermore, disturbances in calcium-phosphorus metabolism may also may influence kidney stone formation through inflammatory and oxidative stress mechanisms. An imbalance in the calcium-phosphorus ratio can trigger local renal inflammatory responses, promoting the release of pro-inflammatory factors such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which exacerbate kidney damage and promote calcium-phosphorus crystal deposition. At the same time, oxidative stress accelerates renal fibrosis and calcification, increasing the risk of stone formation.[35-39] Thus, an elevated serum calcium-phosphorus ratio influences kidney stone formation through multiple pathways, including increased urinary calcium and phosphorus concentrations, imbalance in calcium-phosphorus regulatory molecules, and the involvement of inflammation and oxidative stress.

These mechanisms suggest that maintaining calcium-phosphorus metabolic balance is crucial for kidney health, and that an imbalance in the calcium-phosphorus ratio may be a key driving factor in kidney stone formation.

It is well recognized that urinary calcium and phosphorus excretion are direct determinants of lithogenic risk, as urinary supersaturation of calcium-containing salts is a central step in stone formation.[40,41] Although our study focused on serum measurements rather than urinary indices, systemic disturbances in calcium: phosphorus homeostasis are closely linked to renal mineral handling.[25] Alterations in the serum calcium-phosphorus ratio may therefore reflect upstream regulatory changes that subsequently influence urinary mineral excretion and supersaturation dynamics. However, because urinary biochemical data were not incorporated into the present analysis, future studies integrating both serum and urinary parameters are warranted to further clarify the mechanistic pathway.

Despite this study’s analysis of the association between the serum calcium-phosphorus ratio and kidney stone prevalence using large-scale population data, there are several limitations. First, as a cross-sectional study, it cannot establish a causal relationship, only assessing the association between the calcium-phosphorus ratio and kidney stone prevalence; longitudinal studies are needed in the future to confirm causality. Second, the measurement of the serum calcium-phosphorus ratio was based on a single blood sample, which may not fully reflect long-term calcium-phosphorus metabolism, whereas kidney stone formation is typically a prolonged process.

Third, although we adjusted for a variety of covariates in the analysis, there may still be unmeasured confounding factors that could potentially influence the results. In addition, the diagnosis of kidney stones was based on self-reports from participants, which could lead to recall bias or misclassification, thereby affecting the accuracy of the findings. Finally, as the data were sourced from the NHANES database, with the study population primarily consisting of US individuals, the external validity of the results and their applicability to other races and regions require further verification.

Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion

Results

3.1. Participants and demographic characteristics

This study analyzed NHANES data from 2007 to 2020, including 34,122 eligible participants. Of these, 3207 participants were diagnosed with kidney stones. Serum calcium-phosphorus ratio levels were categorized into 4 groups: Q1 (0.74 to 2.31) with 8423 participants, Q2 (2.32 to 2.54) with 8469 participants, Q3 (2.55 to 2.81) with 8622 participants, and Q4 (2.82 to 10.10) with 8608 participants. Participants in the Q4 group were more likely to have kidney stones, be older, male, Non-Hispanic Black, have less than a high school education, be widowed, have a lower PIR, a higher BMI, higher creatinine levels, higher uric acid levels, lower serum vitamin D levels, lower daily calcium intake, lower daily vitamin D intake, lower daily dietary fiber intake, lower daily moisture intake, and lower daily alcohol intake.

Additionally, they were more likely to have hypertension, diabetes, be former smokers, and not have depression (Table 1).

Table 1

Baseline characteristics of the study participants.

Serum calcium-phosphorus ratio
Q1 (0.74 to 2.31)Q2 (2.32 to 2.54)Q3 (2.55 to 2.81)Q4(2.82 to 10.10)
VariablesTotal (n = 34,122)(n = 8423)(n = 8469)(n = 8622)(n = 8608)P-value
Kidney stone, n (%)<.001
 No30,915 (90.6)7718 (91.6)7736 (91.3)7824 (90.7)7637 (88.7)
 Yes3207 (9.4)705 (8.4)733 (8.7)798 (9.3)971 (11.3)
Age (yr), Median (IQR)50.0 (35.0, 64.0)48.0 (32.0, 62.0)49.0 (34.0, 63.0)50.0 (35.0, 64.0)51.0 (37.0, 65.0)<.001
Gender, n (%)<.001
 Male16,551 (48.5)3280 (38.9)3673 (43.4)4353 (50.5)5245 (60.9)
 Female17,571 (51.5)5143 (61.1)4796 (56.6)4269 (49.5)3363 (39.1)
Race, n (%)<.001
 Mexican American5040 (14.8)1239 (14.7)1272 (15)1276 (14.8)1253 (14.6)
 Other Hispanic3648 (10.7)896 (10.6)961 (11.3)902 (10.5)889 (10.3)
 Non-Hispanic White13,913 (40.8)3618 (43)3429 (40.5)3465 (40.2)3401 (39.5)
 Non-Hispanic Black7301 (21.4)1584 (18.8)1714 (20.2)1902 (22.1)2101 (24.4)
 Other Race4220 (12.4)1086 (12.9)1093 (12.9)1077 (12.5)964 (11.2)
Education, n (%).005
 Less than high school8172 (23.9)1977 (23.5)1942 (22.9)2031 (23.6)2222 (25.8)
 High school or equivalent7788 (22.8)1878 (22.3)1918 (22.6)1916 (22.2)2076 (24.1)
 College or above18,162 (53.2)4568 (54.2)4609 (54.4)4675 (54.2)4310 (50.1)
Marital status, n (%).015
 Married18,136 (53.2)4268 (50.7)4429 (52.3)4746 (55)4693 (54.5)
 Widowed3871 (11.3)916 (10.9)956 (11.3)972 (11.3)1027 (11.9)
 Divorced4362 (12.8)1039 (12.3)1121 (13.2)1072 (12.4)1130 (13.1)
 Separated891 (2.6)247 (2.9)227 (2.7)215 (2.5)202 (2.3)
 Never married4785 (14.0)1374 (16.3)1207 (14.3)1096 (12.7)1108 (12.9)
 Living with partner2077 (6.1)579 (6.9)529 (6.2)521 (6)448 (5.2)
PIR, Median (IQR)2.4 (1.2, 3.8)2.3 (1.1, 3.7)2.5 (1.2, 3.9)2.5 (1.2, 3.9)2.3 (1.2, 3.7).021
BMI (kg/m2), Median (IQR)28.3 (24.5, 32.8)28.0 (24.0, 32.5)28.2 (24.3, 32.5)28.3 (24.5, 32.8)28.7 (25.1, 33.1)<.001
Creatinine (mg/dL), Median (IQR)0.8 (0.7, 1.0)0.8 (0.7, 1.0)0.8 (0.7, 1.0)0.8 (0.7, 1.0)0.9 (0.7, 1.0)<.001
Uric acid (mg/dL), Median (IQR)5.3 (4.4, 6.3)5.2 (4.3, 6.2)5.2 (4.3, 6.2)5.3 (4.4, 6.4)5.5 (4.6, 6.5)<.001
Serum vitamin D (nmol/L), Median (IQR)64.1 (50.5, 72.8)64.1 (49.3, 75.6)64.1 (50.3, 73.2)64.1 (51.3, 72.7)64.1 (50.8, 69.2).027
Daily calcium intake (mg), Median (IQR)853.0 (586.5, 1100.0)878.5 (606.5, 1126.2)859.5 (592.0, 1095.5)841.2 (583.1, 1095.0)831.0 (563.9, 1085.8).019
Daily phosphorus intake (mg), Median (IQR)1275.5 (948.5, 1569.0)1281.0 (958.0, 1581.8)1276.0 (954.5, 1556.5)1273.0 (945.0, 1566.4)1271.5 (937.0, 1570.6).596
Daily vitamin D intake (mcg), Median (IQR)3.7 (1.9, 5.7)3.9 (2.0, 5.9)3.8 (1.9, 5.7)3.6 (1.9, 5.6)3.5 (1.7, 5.4).002
Daily dietary fiber intake (g), Median (IQR)15.7 (10.6, 20.5)15.7 (10.8, 20.3)15.8 (10.7, 20.8)15.7 (10.8, 20.5)15.4 (10.3, 20.4).693
Daily moisture intake (g), Median (IQR)2639.9 (1941.6, 3289.8)2672.4 (1957.0, 3328.9)2633.9 (1952.9, 3296.7)2635.7 (1933.3, 3254.4)2619.6 (1929.6, 3286.4).552
Daily alcohol intake (g), Median (IQR)0.0 (0.0, 8.3)0.0 (0.0, 8.3)0.0 (0.0, 8.3)0.0 (0.0, 8.3)0.0 (0.0, 8.3).075
Physical activity, n (%).259
 Insufficient activity2510 (7.4)580 (6.9)639 (7.5)632 (7.3)659 (7.7)
 Recommended activity31,612 (92.6)7843 (93.1)7830 (92.5)7990 (92.7)7949 (92.3)
Hypertension, n (%)<.001
 No21,677 (63.5)5526 (65.6)5493 (64.9)5451 (63.2)5207 (60.5)
 Yes12,445 (36.5)2897 (34.4)2976 (35.1)3171 (36.8)3401 (39.5)
Diabetes, n (%).156
 No29,559 (86.6)7331 (87)7380 (87.1)7468 (86.6)7380 (85.7)
 Yes4563 (13.4)1092 (13)1089 (12.9)1154 (13.4)1228 (14.3)
Smoking, n (%)<.001
 Never19,145 (56.1)4805 (57)4895 (57.8)4873 (56.5)4572 (53.1)
 Former8158 (23.9)1801 (21.4)1920 (22.7)2121 (24.6)2316 (26.9)
 Now6819 (20.0)1817 (21.6)1654 (19.5)1628 (18.9)1720 (20)
Depression, n (%).018
 No31,392 (92.0)7686 (91.3)7780 (91.9)7996 (92.7)7930 (92.1)
 Yes2730 (8.0)737 (8.7)689 (8.1)626 (7.3)678 (7.9)

BMI = body mass index, g = gram, IQR = interquartile range, PIR = poverty-to-income ratio.

3.2. The association between serum calcium-phosphorus ratio levels and the prevalence of kidney stones

When serum calcium-phosphorus ratio was analyzed as a continuous variable, model 1, which did not adjust for covariates, showed a significant positive association between serum calcium-phosphorus ratio and the prevalence of kidney stones (OR: 1.40, 95% CI: 1.24 to 1.58; P < .001). This association remained significant in both model 2, and model 3 after adjusting for covariates. As serum calcium-phosphorus ratio levels increased, the association became more pronounced, particularly in model 3, where the OR for the fourth quartile was significantly higher than that for the first quartile (OR: 1.32, 95% CI: 1.14 to 1.53).

The trend analysis indicated a significant positive association between serum calcium-phosphorus ratio and the prevalence of kidney stones (P for trend < .001; Table 2). After accounting for all potential confounders, the RCS analysis confirmed a significant positive association between serum calcium-phosphorus ratio and the prevalence of kidney stones, with no evidence of nonlinearity (nonlinearity: P = .558; Fig. 2).

Table 2

The associations between serum calcium-phosphorus ratio levels and the prevalence of kidney stones.

Model 1Model 2Model 3
OR (95% CI)P-valueOR (95% CI)P-valueOR (95% CI)P-value
Continuous1.40 (1.24, 1.58)<.0011.31 (1.15, 1.48)<.0011.29 (1.14, 1.45)<.001
Quartile
 Q1ReferenceReferenceReference
 Q21.13 (0.96, 1.33).1371.11 (0.95, 1.31).1901.12 (0.95, 1.31).178
 Q31.16 (1.02, 1.32).0271.11 (0.97, 1.27).1181.11 (0.97, 1.27).122
 Q41.48 (1.28, 1.72)<.0011.34 (1.16, 1.56)<.0011.32 (1.14, 1.53)<.001
P for trend<.001<.001<.001

Model 1: no covariates adjusted.

Model 2: adjusted for age, gender, race, education, marital status, PIR, BMI, creatinine, uric acid, serum vitamin D.

Model 3: further adjusted for daily calcium intake, daily phosphorus intake, daily vitamin D intake, daily dietary fiber intake, daily moisture intake, daily alcohol intake, physical activity, hypertension, diabetes, smoking, and depression based on model 2.

CI = confidence interval, OR = odds ratio.

Figure 2.

Restricted cubic spline analysis of the association between serum calcium-phosphorus ratio and the prevalence of kidney stones. The reference point (median) is 2.54. CI = confidence interval, OR = odds ratio.

Figure image at the original source: open the original paper. This file is not included in this text import.

3.3. Subgroup analyses and interaction effects

Subgroup and interaction analyses were conducted based on age, gender, race, education level, marital status, daily moisture intake, and physical activity. The subgroup analysis revealed that the positive association remained consistent across multiple subgroups, with no significant interactions observed (Fig. 3).

Figure 3.

Subgroup analysis and interaction effects for the association between serum calcium-phosphorus ratio and the prevalence of kidney stones. CI = confidence interval, OR = odds ratio.

Figure image at the original source: open the original paper. This file is not included in this text import.

3.4. Sensitivity analysis results

In the sensitivity analysis, different data processing methods were used to validate the robustness of the results: using the complete dataset (without imputation) and adjusting for multiple covariates, the results showed a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones (OR: 1.41, 95% CI: 1.16 to 1.71, P < .001); after excluding the top and bottom 2.5% extreme values and adjusting for multiple covariates, the results also showed a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones (OR: 1.34, 95% CI: 1.16 to 1.54, P < .001; Table 3).

Table 3

Sensitivity analysis.

Model 1Model 2Model 3
Sensitivity analysis methodsOR (95% CI)P-valueOR (95% CI)P-valueOR (95% CI)P-value
The complete dataset, without imputation1.55 (1.28, 1.87)<.0011.41 (1.17, 1.70)<.0011.41 (1.16, 1.71)<.001
After excluding the top and bottom 2.5% extreme values1.51 (1.30, 1.75)<.0011.35 (1.17, 1.56)<.0011.34 (1.16, 1.54)<.001

Model 1: no covariates adjusted.

Model 2: adjusted for age, gender, race, education, marital status, PIR, BMI, creatinine, uric acid, serum vitamin D.

Model 3: further adjusted for daily calcium intake, daily phosphorus intake, daily vitamin D intake, daily dietary fiber intake, daily moisture intake, daily alcohol intake, physical activity, hypertension, diabetes, smoking, and depression based on model 2.

CI = confidence interval, OR = odds ratio.

Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results

Conclusion

This study, based on large-scale population data analysis, found a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones, and this association with no evidence of nonlinearity. The balance of calcium-phosphorus metabolism is crucial for the prevention of kidney stone formation, and an elevated serum calcium-phosphorus ratio may be an independent risk factor for kidney stone formation. Future research should further explore the potential role of calcium-phosphorus metabolic interventions and the serum calcium-phosphorus ratio as a risk marker for kidney stones.

Source: 5. Conclusion
Authors’ abstract

Kidney stones are a common urological disease with a complex pathogenesis influenced by multiple factors. Calcium and phosphorus, as essential minerals in the body, may be closely related to the prevalence of kidney stones. However, studies on the association between the serum calcium-phosphorus ratio and the prevalence of kidney stones remain limited, and systematic analyses are lacking. This study utilized data from the 2007 to 2020 National Health and Nutrition Examination Survey (NHANES), including a total of 34,122 participants. Multivariable logistic regression models were employed, progressively adjusting for demographic characteristics, health status, and dietary factors to assess the association between the serum calcium-phosphorus ratio and kidney stone prevalence.

Restricted cubic spline (RCS) analysis was used to explore any potential nonlinear associations between the serum calcium-phosphorus ratio and kidney stone prevalence. Subgroup and interaction analyses were conducted to further investigate the influence of covariates on this association. Among the 34,122 participants, 3207 were diagnosed with kidney stones. The model adjusted for multiple covariates showed a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones (OR: 1.29, 95% CI: 1.14 to 1.45, P < .001). RCS analysis indicated no significant nonlinear association between the serum calcium-phosphorus ratio and the prevalence of kidney stones (P for nonlinearity = 0.558).

Subgroup analysis revealed that this positive association remained consistent across multiple subgroups, with no significant interactions observed. Sensitivity analysis further confirmed the robustness of these findings. This study demonstrates a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones, and this association is linear. Further research is needed to explore the potential role of the serum calcium-phosphorus ratio as a risk marker for kidney stones and to identify possible intervention strategies.

Read the full paper

1. Introduction

Kidney stones are a common urological disease worldwide, with an increasing incidence trend year by year.[1,2] The causes of kidney stone formation are complex, involving genetic, environmental, dietary, and other factors.[3,4] In recent years, increasing attention has been paid to the relationship between mineral balance in the blood and kidney stone formation, particularly the role of minerals such as calcium and phosphorus.[5,6] However, while the independent effects of calcium and phosphorus have been widely studied, the potential role of the serum calcium-phosphorus ratio as a risk factor remains poorly understood.

Calcium-phosphorus homeostasis is not only a key indicator of bone metabolism but also plays a crucial role in maintaining overall mineral balance, regulating parathyroid function, and supporting cardiovascular health.[7,8] Calcium is a major component of bones and teeth and is involved in vital physiological functions such as nerve conduction, muscle contraction, and blood clotting.[9,10] Phosphorus, on the other hand, is essential for cellular energy metabolism, maintaining cell membrane integrity, and nucleic acid synthesis.[11,12] The balance between calcium and phosphorus is critical for sustaining normal physiological functions.

When this balance is disrupted, it can lead to a range of health issues, such as osteoporosis, parathyroid dysfunction, and cardiovascular disease.[7,8] Studies have suggested that disturbances in calcium-phosphorus metabolism may be associated with various metabolic diseases, particularly in the formation of kidney stones, where calcium-phosphorus metabolic imbalances may play a key role.[13,14] However, despite numerous studies on the independent effects of calcium and phosphorus, systematic research on the direct association between the calcium-phosphorus ratio and kidney stone prevalence is still lacking, especially in studies based on large-scale population samples.

Rather than isolated alterations in serum calcium or phosphorus, their relative balance may better reflect systemic mineral homeostasis. The calcium-phosphorus ratio has been proposed as a simple and inexpensive composite marker for identifying disorders of calcium-phosphorus metabolism, particularly in the screening of primary hyperparathyroidism.[15,16] Recent population-based research has further applied the calcium-phosphorus ratio in epidemiological analyses of metabolic diseases, suggesting that it may capture subtle mineral imbalance not fully reflected by either mineral alone.[17] However, its potential relevance to nephrolithiasis has not been systematically investigated in large-scale population studies.

This study, based on data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2020, aims to systematically evaluate the association between the serum calcium-phosphorus ratio and the prevalence of kidney stones. By utilizing this large-scale, nationally representative population data, we explore whether the serum calcium-phosphorus ratio serves as an independent risk factor for kidney stone formation, while controlling for other potential confounding factors. This study not only fills gaps in the existing literature but also provides new insights into the prevention and management of kidney stones.

The central objective of this study was to determine whether a significant positive association exists between the serum calcium-phosphorus ratio and the prevalence of kidney stones. If confirmed, this finding may identify a new risk marker and offer a scientific basis for kidney stone risk assessment and intervention strategies, as well as provide new perspectives on its pathogenesis and preventive measures.

2. Materials and methods

2.1. Data source

The data used in this study were sourced from NHANES. NHANES is an ongoing, nationally representative population survey led by the Centers for Disease Control and Prevention (CDC), aimed at assessing the health and nutritional status of the adult and child in the United States. The survey employs a stratified, multistage probability sampling design to ensure that the findings are representative. For this study, data from NHANES between 2007 and 2020 were selected. NHANES data collection includes 3 major components: comprehensive questionnaires, clinical examinations, and laboratory tests.

To ensure the representativeness and reliability of the data, we used the sampling weights provided by NHANES to adjust for differences across survey years and population groups. The data analysis utilized merged multi-cycle weights to ensure that the results reflect the overall adult population of the United States. All data were obtained from the publicly available NHANES database, and no personally identifiable information was involved, thus no additional ethical approval was required. To ensure the accuracy and broad applicability of the data, the NHANES data collection and survey design followed strict standardization protocols, and detailed descriptions of all variable definitions and methodologies are available on the NHANES website.[18,19]

2.2. Study population

The data for this study were obtained from participants in NHANES from 2007 to 2020, with an initial sample of 66,148 individuals. During the screening process, individuals younger than 20 years of age (n = 27,715), those with missing data on kidney stones (n = 104), and those missing data on the serum calcium-phosphorus ratio (n = 4207) were excluded. Ultimately, 34,122 participants were included in the final analysis. Figure 1 presents the participant selection flowchart.

Figure 1.

Flowchart of the participant selection process. NHANES = National Health and Nutrition Examination Survey.

Figure image at the original source: open the original paper. This file is not included in this text import.

2.3. Measurement of serum calcium, serum phosphorus, and calculation of the ratio

This study utilized laboratory data provided by NHANES, with serum calcium and serum phosphorus measured using the automated analysis systems LX20 and DxC800, respectively. Serum calcium measurement: Serum calcium was measured using the ion-selective electrode (ISE) method. The calcium ion concentration was calculated using the Nernst equation, based on the potential change generated by the binding of calcium ions to the ionophore on the electrode surface. Serum phosphorus measurement: serum phosphorus was measured using a timed-rate method. In this process, phosphorus reacts with ammonium molybdate in an acidic solution to form a colored phosphomolybdate complex.

The change in absorbance, measured at a wavelength of 365 nm, is directly proportional to the phosphorus concentration. Calculation of the calcium-phosphorus ratio: the calcium-phosphorus ratio was calculated by dividing the serum calcium concentration (mg/dL) by the serum phosphorus concentration (mg/dL). This ratio was used to evaluate the association with kidney stone prevalence.

2.4. Definition of kidney stones

In this study, the definition of kidney stones was based on participants’ self-reports from the NHANES health questionnaire. Participants were asked whether they had ever been diagnosed with kidney stones by a healthcare professional. The specific question was: “Has a doctor or other health professional ever told you that you had kidney stones?” Individuals who answered “Yes” were identified as having a history of kidney stones and were classified into the kidney stone group.

2.5. Covariates

In the analysis of the association between the serum calcium-phosphorus ratio and the prevalence of kidney stones, several covariates that could potentially influence the results were adjusted for. These covariates covered demographic characteristics, health status, dietary factors, and lifestyle factors, including: age, gender, race/ethnicity (Mexican American, Other Hispanic, Non-Hispanic White, Non-Hispanic Black, and Other Race), education level (less than high school, high school or equivalent, college or above), marital status (married, widowed, divorced, separated, never married, living with a partner), poverty-to-income ratio (PIR), body mass index (BMI), serum creatinine levels, uric acid levels, serum vitamin D levels, daily calcium intake, daily phosphorus intake, daily vitamin D intake, daily dietary fiber intake, daily moisture intake, daily alcohol intake, physical activity (recommended activity and insufficient activity),[20] hypertension (yes/no), diabetes (yes/no), smoking status (never smoked, former smoker, current smoker),[21] and depression status (yes/no).

All these covariates were included in the multivariable analysis models to control for their potential influence on the association between the serum calcium-phosphorus ratio and the prevalence of kidney stones.

2.6. Statistical analyses

Calcium-phosphorus ratio levels were divided into 4 quartiles: Q1, Q2, Q3, and Q4. Missing values were imputed as follows: mode imputation for categorical variables, mean imputation for normally distributed continuous variables, and median imputation for skewed continuous variables. Categorical variables were presented as percentages and compared using a weighted chi-square test. For normally distributed continuous variables, results were expressed as mean ± standard deviation, and group comparisons were made using a weighted t-test. For non-normally distributed continuous variables, median and interquartile range (IQR) were used for description, and comparisons were conducted using a weighted Kruskal: Wallis test.

To explore the association between calcium-phosphorus ratio levels and the prevalence of kidney stones, 3 multivariable logistic regression models were constructed. Model 1 was unadjusted for any covariates. Model 2 was based on model 1, with adjustments for age, gender, race, education level, marital status, PIR, BMI, serum creatinine, uric acid, and serum vitamin D levels. Model 3 was adjusted for all covariates. Restricted cubic spline (RCS) analysis was used to explore the nonlinear association between the calcium-phosphorus ratio and the prevalence of kidney stones.

Subgroup analyses were conducted to further investigate the association between calcium-phosphorus ratio and kidney stone prevalence in different populations. To examine the potential influence of different covariates on the association between calcium-phosphorus ratio and the prevalence of kidney stones, interaction analyses were performed to test the interactions between calcium-phosphorus ratio and key covariates. All statistical analyses were performed using R software (version 4.2.2; R Foundation for Statistical Computing, Vienna, Austria) and Free Statistics software (version 1.9). A 2-sided P-value of <.05 was considered statistically significant.

3. Results

3.1. Participants and demographic characteristics

This study analyzed NHANES data from 2007 to 2020, including 34,122 eligible participants. Of these, 3207 participants were diagnosed with kidney stones. Serum calcium-phosphorus ratio levels were categorized into 4 groups: Q1 (0.74 to 2.31) with 8423 participants, Q2 (2.32 to 2.54) with 8469 participants, Q3 (2.55 to 2.81) with 8622 participants, and Q4 (2.82 to 10.10) with 8608 participants. Participants in the Q4 group were more likely to have kidney stones, be older, male, Non-Hispanic Black, have less than a high school education, be widowed, have a lower PIR, a higher BMI, higher creatinine levels, higher uric acid levels, lower serum vitamin D levels, lower daily calcium intake, lower daily vitamin D intake, lower daily dietary fiber intake, lower daily moisture intake, and lower daily alcohol intake.

Additionally, they were more likely to have hypertension, diabetes, be former smokers, and not have depression (Table 1).

Table 1

Baseline characteristics of the study participants.

Serum calcium-phosphorus ratio
Q1 (0.74 to 2.31)Q2 (2.32 to 2.54)Q3 (2.55 to 2.81)Q4(2.82 to 10.10)
VariablesTotal (n = 34,122)(n = 8423)(n = 8469)(n = 8622)(n = 8608)P-value
Kidney stone, n (%)<.001
 No30,915 (90.6)7718 (91.6)7736 (91.3)7824 (90.7)7637 (88.7)
 Yes3207 (9.4)705 (8.4)733 (8.7)798 (9.3)971 (11.3)
Age (yr), Median (IQR)50.0 (35.0, 64.0)48.0 (32.0, 62.0)49.0 (34.0, 63.0)50.0 (35.0, 64.0)51.0 (37.0, 65.0)<.001
Gender, n (%)<.001
 Male16,551 (48.5)3280 (38.9)3673 (43.4)4353 (50.5)5245 (60.9)
 Female17,571 (51.5)5143 (61.1)4796 (56.6)4269 (49.5)3363 (39.1)
Race, n (%)<.001
 Mexican American5040 (14.8)1239 (14.7)1272 (15)1276 (14.8)1253 (14.6)
 Other Hispanic3648 (10.7)896 (10.6)961 (11.3)902 (10.5)889 (10.3)
 Non-Hispanic White13,913 (40.8)3618 (43)3429 (40.5)3465 (40.2)3401 (39.5)
 Non-Hispanic Black7301 (21.4)1584 (18.8)1714 (20.2)1902 (22.1)2101 (24.4)
 Other Race4220 (12.4)1086 (12.9)1093 (12.9)1077 (12.5)964 (11.2)
Education, n (%).005
 Less than high school8172 (23.9)1977 (23.5)1942 (22.9)2031 (23.6)2222 (25.8)
 High school or equivalent7788 (22.8)1878 (22.3)1918 (22.6)1916 (22.2)2076 (24.1)
 College or above18,162 (53.2)4568 (54.2)4609 (54.4)4675 (54.2)4310 (50.1)
Marital status, n (%).015
 Married18,136 (53.2)4268 (50.7)4429 (52.3)4746 (55)4693 (54.5)
 Widowed3871 (11.3)916 (10.9)956 (11.3)972 (11.3)1027 (11.9)
 Divorced4362 (12.8)1039 (12.3)1121 (13.2)1072 (12.4)1130 (13.1)
 Separated891 (2.6)247 (2.9)227 (2.7)215 (2.5)202 (2.3)
 Never married4785 (14.0)1374 (16.3)1207 (14.3)1096 (12.7)1108 (12.9)
 Living with partner2077 (6.1)579 (6.9)529 (6.2)521 (6)448 (5.2)
PIR, Median (IQR)2.4 (1.2, 3.8)2.3 (1.1, 3.7)2.5 (1.2, 3.9)2.5 (1.2, 3.9)2.3 (1.2, 3.7).021
BMI (kg/m2), Median (IQR)28.3 (24.5, 32.8)28.0 (24.0, 32.5)28.2 (24.3, 32.5)28.3 (24.5, 32.8)28.7 (25.1, 33.1)<.001
Creatinine (mg/dL), Median (IQR)0.8 (0.7, 1.0)0.8 (0.7, 1.0)0.8 (0.7, 1.0)0.8 (0.7, 1.0)0.9 (0.7, 1.0)<.001
Uric acid (mg/dL), Median (IQR)5.3 (4.4, 6.3)5.2 (4.3, 6.2)5.2 (4.3, 6.2)5.3 (4.4, 6.4)5.5 (4.6, 6.5)<.001
Serum vitamin D (nmol/L), Median (IQR)64.1 (50.5, 72.8)64.1 (49.3, 75.6)64.1 (50.3, 73.2)64.1 (51.3, 72.7)64.1 (50.8, 69.2).027
Daily calcium intake (mg), Median (IQR)853.0 (586.5, 1100.0)878.5 (606.5, 1126.2)859.5 (592.0, 1095.5)841.2 (583.1, 1095.0)831.0 (563.9, 1085.8).019
Daily phosphorus intake (mg), Median (IQR)1275.5 (948.5, 1569.0)1281.0 (958.0, 1581.8)1276.0 (954.5, 1556.5)1273.0 (945.0, 1566.4)1271.5 (937.0, 1570.6).596
Daily vitamin D intake (mcg), Median (IQR)3.7 (1.9, 5.7)3.9 (2.0, 5.9)3.8 (1.9, 5.7)3.6 (1.9, 5.6)3.5 (1.7, 5.4).002
Daily dietary fiber intake (g), Median (IQR)15.7 (10.6, 20.5)15.7 (10.8, 20.3)15.8 (10.7, 20.8)15.7 (10.8, 20.5)15.4 (10.3, 20.4).693
Daily moisture intake (g), Median (IQR)2639.9 (1941.6, 3289.8)2672.4 (1957.0, 3328.9)2633.9 (1952.9, 3296.7)2635.7 (1933.3, 3254.4)2619.6 (1929.6, 3286.4).552
Daily alcohol intake (g), Median (IQR)0.0 (0.0, 8.3)0.0 (0.0, 8.3)0.0 (0.0, 8.3)0.0 (0.0, 8.3)0.0 (0.0, 8.3).075
Physical activity, n (%).259
 Insufficient activity2510 (7.4)580 (6.9)639 (7.5)632 (7.3)659 (7.7)
 Recommended activity31,612 (92.6)7843 (93.1)7830 (92.5)7990 (92.7)7949 (92.3)
Hypertension, n (%)<.001
 No21,677 (63.5)5526 (65.6)5493 (64.9)5451 (63.2)5207 (60.5)
 Yes12,445 (36.5)2897 (34.4)2976 (35.1)3171 (36.8)3401 (39.5)
Diabetes, n (%).156
 No29,559 (86.6)7331 (87)7380 (87.1)7468 (86.6)7380 (85.7)
 Yes4563 (13.4)1092 (13)1089 (12.9)1154 (13.4)1228 (14.3)
Smoking, n (%)<.001
 Never19,145 (56.1)4805 (57)4895 (57.8)4873 (56.5)4572 (53.1)
 Former8158 (23.9)1801 (21.4)1920 (22.7)2121 (24.6)2316 (26.9)
 Now6819 (20.0)1817 (21.6)1654 (19.5)1628 (18.9)1720 (20)
Depression, n (%).018
 No31,392 (92.0)7686 (91.3)7780 (91.9)7996 (92.7)7930 (92.1)
 Yes2730 (8.0)737 (8.7)689 (8.1)626 (7.3)678 (7.9)

BMI = body mass index, g = gram, IQR = interquartile range, PIR = poverty-to-income ratio.

3.2. The association between serum calcium-phosphorus ratio levels and the prevalence of kidney stones

When serum calcium-phosphorus ratio was analyzed as a continuous variable, model 1, which did not adjust for covariates, showed a significant positive association between serum calcium-phosphorus ratio and the prevalence of kidney stones (OR: 1.40, 95% CI: 1.24 to 1.58; P < .001). This association remained significant in both model 2, and model 3 after adjusting for covariates. As serum calcium-phosphorus ratio levels increased, the association became more pronounced, particularly in model 3, where the OR for the fourth quartile was significantly higher than that for the first quartile (OR: 1.32, 95% CI: 1.14 to 1.53).

The trend analysis indicated a significant positive association between serum calcium-phosphorus ratio and the prevalence of kidney stones (P for trend < .001; Table 2). After accounting for all potential confounders, the RCS analysis confirmed a significant positive association between serum calcium-phosphorus ratio and the prevalence of kidney stones, with no evidence of nonlinearity (nonlinearity: P = .558; Fig. 2).

Table 2

The associations between serum calcium-phosphorus ratio levels and the prevalence of kidney stones.

Model 1Model 2Model 3
OR (95% CI)P-valueOR (95% CI)P-valueOR (95% CI)P-value
Continuous1.40 (1.24, 1.58)<.0011.31 (1.15, 1.48)<.0011.29 (1.14, 1.45)<.001
Quartile
 Q1ReferenceReferenceReference
 Q21.13 (0.96, 1.33).1371.11 (0.95, 1.31).1901.12 (0.95, 1.31).178
 Q31.16 (1.02, 1.32).0271.11 (0.97, 1.27).1181.11 (0.97, 1.27).122
 Q41.48 (1.28, 1.72)<.0011.34 (1.16, 1.56)<.0011.32 (1.14, 1.53)<.001
P for trend<.001<.001<.001

Model 1: no covariates adjusted.

Model 2: adjusted for age, gender, race, education, marital status, PIR, BMI, creatinine, uric acid, serum vitamin D.

Model 3: further adjusted for daily calcium intake, daily phosphorus intake, daily vitamin D intake, daily dietary fiber intake, daily moisture intake, daily alcohol intake, physical activity, hypertension, diabetes, smoking, and depression based on model 2.

CI = confidence interval, OR = odds ratio.

Figure 2.

Restricted cubic spline analysis of the association between serum calcium-phosphorus ratio and the prevalence of kidney stones. The reference point (median) is 2.54. CI = confidence interval, OR = odds ratio.

Figure image at the original source: open the original paper. This file is not included in this text import.

3.3. Subgroup analyses and interaction effects

Subgroup and interaction analyses were conducted based on age, gender, race, education level, marital status, daily moisture intake, and physical activity. The subgroup analysis revealed that the positive association remained consistent across multiple subgroups, with no significant interactions observed (Fig. 3).

Figure 3.

Subgroup analysis and interaction effects for the association between serum calcium-phosphorus ratio and the prevalence of kidney stones. CI = confidence interval, OR = odds ratio.

Figure image at the original source: open the original paper. This file is not included in this text import.

3.4. Sensitivity analysis results

In the sensitivity analysis, different data processing methods were used to validate the robustness of the results: using the complete dataset (without imputation) and adjusting for multiple covariates, the results showed a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones (OR: 1.41, 95% CI: 1.16 to 1.71, P < .001); after excluding the top and bottom 2.5% extreme values and adjusting for multiple covariates, the results also showed a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones (OR: 1.34, 95% CI: 1.16 to 1.54, P < .001; Table 3).

Table 3

Sensitivity analysis.

Model 1Model 2Model 3
Sensitivity analysis methodsOR (95% CI)P-valueOR (95% CI)P-valueOR (95% CI)P-value
The complete dataset, without imputation1.55 (1.28, 1.87)<.0011.41 (1.17, 1.70)<.0011.41 (1.16, 1.71)<.001
After excluding the top and bottom 2.5% extreme values1.51 (1.30, 1.75)<.0011.35 (1.17, 1.56)<.0011.34 (1.16, 1.54)<.001

Model 1: no covariates adjusted.

Model 2: adjusted for age, gender, race, education, marital status, PIR, BMI, creatinine, uric acid, serum vitamin D.

Model 3: further adjusted for daily calcium intake, daily phosphorus intake, daily vitamin D intake, daily dietary fiber intake, daily moisture intake, daily alcohol intake, physical activity, hypertension, diabetes, smoking, and depression based on model 2.

CI = confidence interval, OR = odds ratio.

4. Discussion

In this study, we analyzed the association between the serum calcium-phosphorus ratio and the prevalence of kidney stones based on data from NHANES (2007 to 2020). The results indicated a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones. Multivariable logistic regression analysis showed that this association remained significant even after adjusting for various potential confounding factors. Specifically, individuals in the highest quartile (Q4) of the serum calcium-phosphorus ratio had a significantly higher prevalence of kidney stones compared to those in the lowest quartile (Q1).

RCS analysis further confirmed that this positive association was linear, with no evidence of nonlinearity. The serum calcium-phosphorus ratio and the serum phosphorus-to-calcium ratio are mathematically reciprocal transformations and therefore convey identical statistical information. Accordingly, the choice between them does not affect statistical inference. We selected the serum calcium-phosphorus ratio because it more directly reflects the established role of calcium as the principal component of most kidney stones and enhances clinical interpretability. Existing research suggests that disturbances in calcium-phosphorus metabolism are closely related to the prevalence of kidney stones.

Taylor et al’s study included 356 men with newly diagnosed symptomatic kidney stones and 712 healthy men as a control group. Using a prospective nested case-control study design, they analyzed the association between plasma calcium-phosphorus regulatory hormones and the prevalence of kidney stones. The results indicated that calcium-phosphorus metabolic disturbances may be a key factor in the formation of kidney stones.[13] In a study by Zhang et al, 24 patients with calcium stone and 21 non-stone controls were included, with a focus on biomarkers related to calcium-phosphorus metabolism.

The study compared the differences in calcium-phosphorus regulatory proteins between the 2 groups and found that the excretion of exosomes carrying calcium-phosphorus regulatory proteins was significantly reduced in the urine of calcium stone patients, further suggesting that abnormalities in calcium-phosphorus metabolism may play an important role in the formation of kidney stones.[22]

Beyond the independent effects of calcium and phosphorus, the serum calcium-phosphorus ratio may serve as a more integrated marker of systemic mineral homeostasis. An altered ratio reflects a relative predominance of one mineral over the other and may indicate dysregulation within the tightly regulated calcium: phosphorus: PTH: vitamin D axis.[23] Such systemic imbalance may influence renal mineral handling and alter urinary supersaturation dynamics, thereby modifying crystal formation risk.[24,25] Therefore, the positive association observed between the serum calcium-phosphorus ratio and kidney stone prevalence may reflect broader disturbances in mineral regulation rather than the isolated effect of either calcium or phosphorus alone.

Disturbances in calcium-phosphorus metabolism are closely related to the formation of kidney stones. Calcium and phosphorus are key minerals for maintaining bone health and various physiological functions, and their metabolic imbalance in the kidneys may directly contribute to kidney stone formation. First, an elevated calcium-phosphorus ratio may lead to increased saturation of calcium and phosphorus in the urine, which in turn promotes the formation of calcium oxalate or calcium phosphate crystals. Once these crystals deposit in the renal tubules, they can become the nucleus for kidney stone formation.[26-28] Second, the regulation of calcium-phosphorus metabolism involves several key molecules and hormones, among which fibroblast growth factor 23 (FGF23) plays a central role in regulating serum phosphorus levels.

FGF23 inhibits the synthesis of 1,25-dihydroxyvitamin D, reduces the intestinal absorption of phosphorus, and increases renal phosphorus excretion. When serum phosphorus levels rise, FGF23 secretion increases, leading to greater phosphorus excretion and disruption of the calcium-phosphorus balance. This process, accompanied by reduced calcium absorption, may result in increased urinary calcium excretion, thereby promoting the formation of kidney stones.[13,29-31] The calcium-sensing receptor (CaSR) is another important molecule in the regulation of calcium-phosphorus metabolism in the kidneys. When serum calcium levels are elevated, CaSR is activated, reducing calcium reabsorption and increasing urinary calcium excretion.

Although this mechanism helps maintain serum calcium levels in the short term, prolonged urinary calcium excretion may promote kidney stone formation.[32-34] Furthermore, disturbances in calcium-phosphorus metabolism may also may influence kidney stone formation through inflammatory and oxidative stress mechanisms. An imbalance in the calcium-phosphorus ratio can trigger local renal inflammatory responses, promoting the release of pro-inflammatory factors such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which exacerbate kidney damage and promote calcium-phosphorus crystal deposition. At the same time, oxidative stress accelerates renal fibrosis and calcification, increasing the risk of stone formation.[35-39] Thus, an elevated serum calcium-phosphorus ratio influences kidney stone formation through multiple pathways, including increased urinary calcium and phosphorus concentrations, imbalance in calcium-phosphorus regulatory molecules, and the involvement of inflammation and oxidative stress.

These mechanisms suggest that maintaining calcium-phosphorus metabolic balance is crucial for kidney health, and that an imbalance in the calcium-phosphorus ratio may be a key driving factor in kidney stone formation.

It is well recognized that urinary calcium and phosphorus excretion are direct determinants of lithogenic risk, as urinary supersaturation of calcium-containing salts is a central step in stone formation.[40,41] Although our study focused on serum measurements rather than urinary indices, systemic disturbances in calcium: phosphorus homeostasis are closely linked to renal mineral handling.[25] Alterations in the serum calcium-phosphorus ratio may therefore reflect upstream regulatory changes that subsequently influence urinary mineral excretion and supersaturation dynamics. However, because urinary biochemical data were not incorporated into the present analysis, future studies integrating both serum and urinary parameters are warranted to further clarify the mechanistic pathway.

Despite this study’s analysis of the association between the serum calcium-phosphorus ratio and kidney stone prevalence using large-scale population data, there are several limitations. First, as a cross-sectional study, it cannot establish a causal relationship, only assessing the association between the calcium-phosphorus ratio and kidney stone prevalence; longitudinal studies are needed in the future to confirm causality. Second, the measurement of the serum calcium-phosphorus ratio was based on a single blood sample, which may not fully reflect long-term calcium-phosphorus metabolism, whereas kidney stone formation is typically a prolonged process.

Third, although we adjusted for a variety of covariates in the analysis, there may still be unmeasured confounding factors that could potentially influence the results. In addition, the diagnosis of kidney stones was based on self-reports from participants, which could lead to recall bias or misclassification, thereby affecting the accuracy of the findings. Finally, as the data were sourced from the NHANES database, with the study population primarily consisting of US individuals, the external validity of the results and their applicability to other races and regions require further verification.

5. Conclusion

This study, based on large-scale population data analysis, found a significant positive association between the serum calcium-phosphorus ratio and the prevalence of kidney stones, and this association with no evidence of nonlinearity. The balance of calcium-phosphorus metabolism is crucial for the prevention of kidney stone formation, and an elevated serum calcium-phosphorus ratio may be an independent risk factor for kidney stone formation. Future research should further explore the potential role of calcium-phosphorus metabolic interventions and the serum calcium-phosphorus ratio as a risk marker for kidney stones.

Author contributions

Conceptualization: Jian Qin, Xia Liu.

Data curation: Jian Qin, Xia Liu, Miao Yu.

Formal analysis: Jian Qin, Xia Liu, Miao Yu.

Methodology: Xia Liu, Miao Yu.

Software: Jian Qin.

Supervision: Miao Yu.

Validation: Xia Liu.

Visualization: Jian Qin.

Writing: original draft: Jian Qin, Xia Liu, Miao Yu.

Writing: review & editing: Jian Qin, Xia Liu, Miao Yu.

Abbreviations:

BMI

body mass index

CaSR

calcium-sensing receptor

CDC

Centers for Disease Control and Prevention

CI

confidence interval

FGF23

fibroblast growth factor 23

IL-6

interleukin-6

IQR

interquartile range

ISE

ion-selective electrode

NHANES

National Health and Nutrition Examination Survey

OR

odds ratio

PIR

poverty-to-income ratio

RCS

restricted cubic spline

TNF-α

tumor necrosis factor-alpha

This study was supported by the following funding sources: Zigong Municipal Health and Science Research Project (Grant No. 22yb079); and Zigong Key Science and Technology Plan Project (Grant No. 2020ZC28).

The study was reviewed and approved by the Institutional Review Board of the CDC’s National Center for Health Statistics, and written informed consent was obtained from all participants. The research followed the ethical principles outlined in the Helsinki Declaration. Since this study utilized secondary data from NHANES, no further ethics approval was required.

The authors have no conflicts of interest to disclose.

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

How to cite this article: Qin J, Liu X, Yu M. Positive association between serum calcium-phosphorus ratio and kidney stone prevalence: Analysis of NHANES data (2007 to 2020). Medicine 2026;105:17(e48432).

References

[1] Romero V Akpinar H Assimos DG . Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol . 2010 ;12 :e86Not reported96 . 20811557 PMC2931286
[2] Abufaraj M Xu T Cao C . Prevalence and trends in kidney stone among adults in the USA: analyses of national health and nutrition examination survey 2007-2018 data. Eur Urol Focus . 2021 ;7 :1468Not reported75 . 32900675 10.1016/j.euf.2020.08.011
[3] Evan AP . Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol . 2010 ;25 :831Not reported41 . 19198886 10.1007/s00467-009-1116-y PMC2839518
[4] Edvardsson VO Goldfarb DS Lieske JC . Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol . 2013 ;28 :1923Not reported42 . 23334384 10.1007/s00467-012-2329-z PMC4138059
[5] Worcester EM Coe FL . Clinical practice. Calcium kidney stones. N Engl J Med . 2010 ;363 :954Not reported63 . 20818905 10.1056/NEJMcp1001011 PMC3192488
[6] Prié D Beck L Silve C Friedlander G . Hypophosphatemia and calcium nephrolithiasis. Nephron Exp Nephrol . 2004 ;98 :e50Not reported4 . 15499207 10.1159/000080256
[7] Moe SM . Disorders involving calcium, phosphorus, and magnesium. Prim Care . 2008 ;35 :215Not reported37 , v. 18486714 10.1016/j.pop.2008.01.007 PMC2486454
[8] Kovacs CS . Calcium, phosphorus, and bone metabolism in the fetus and newborn. Early Hum Dev . 2015 ;91 :623Not reported8 . 26363942 10.1016/j.earlhumdev.2015.08.007
[9] Peacock M . Calcium metabolism in health and disease. Clin J Am Soc Nephrol . 2010 ;5 (Suppl 1 ):S23Not reported30 . 20089499 10.2215/CJN.05910809
[10] Trailokya A Srivastava A Bhole M Zalte N . Calcium and calcium salts. J Assoc Physicians India . 2017 ;65 :100Not reported3 . 28457049
[11] Sun M Wu X Yu Y . Disorders of calcium and phosphorus metabolism and the proteomics/metabolomics-based research. Front Cell Dev Biol . 2020 ;8 :576110 . 33015068 10.3389/fcell.2020.576110 PMC7511772
[12] Elser JJ . Phosphorus: a limiting nutrient for humanity? Curr Opin Biotechnol . 2012 ;23 :833Not reported8 . 22465489 10.1016/j.copbio.2012.03.001
[13] Taylor EN Hoofnagle AN Curhan GC . Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones. Clin J Am Soc Nephrol . 2015 ;10 :667Not reported75 . 25623233 10.2215/CJN.07060714 PMC4386254
[14] Taylor JG Bushinsky DA . Calcium and phosphorus homeostasis. Blood Purif . 2009 ;27 :387Not reported94 . 19299893 10.1159/000209740
[15] Bestepe N Cuhaci FN Polat B . Serum calcium/phosphorus ratio in biochemical screening of primary hyperparathyroidism. Rev Assoc Med Bras (1992) . 2022 ;68 :1668Not reported74 . 36449791 10.1590/1806-9282.20220645 PMC9779951
[16] Madeo B De Vincentis S Kara E . Reliability of calcium-phosphorus (Ca/P) ratio as a new, accurate and inexpensive tool in the diagnosis of some Ca-P disorders. J Endocrinol Invest . 2019 ;42 :1041Not reported9 . 30796757 10.1007/s40618-019-01025-6
[17] Kang J Xin S Zhang H . Investigating the association between calcium-phosphorus balance and osteoarthritis: evidence from NHANES 2007-2016. Medicine (Baltim) . 2025 ;104 :e43301 . 10.1097/MD.0000000000043301 PMC12282842 40696700
[18] Schuna JM Jr Johnson WD Tudor-Locke C . Adult self-reported and objectively monitored physical activity and sedentary behavior: NHANES 2005-2006. Int J Behav Nutr Phys Act . 2013 ;10 :126 . 24215625 10.1186/1479-5868-10-126 PMC3828579
[19] Kahende JW Adhikari B Maurice E Rock V Malarcher A . Disparities in health care utilization by smoking status--NHANES 1999-2004. Int J Environ Res Public Health . 2009 ;6 :1095Not reported106 . 19440435 10.3390/ijerph6031095 PMC2672402
[20] Zhu Y Wang Z . Association between joint physical activity and healthy dietary patterns and hypertension in US adults: cross-sectional NHANES study. BMC Public Health . 2024 ;24 :855 . 38504199 10.1186/s12889-024-18346-8 PMC10953194
[21] Veldheer S Yingst J Zhu J Foulds J . Ten-year weight gain in smokers who quit, smokers who continued smoking and never smokers in the United States, NHANES 2003-2012. Int J Obes (Lond) . 2015 ;39 :1727Not reported32 . 26155918 10.1038/ijo.2015.127 PMC4976446
[22] Zhang J Kumar S Jayachandran M . Excretion of urine extracellular vesicles bearing markers of activated immune cells and calcium/phosphorus physiology differ between calcium kidney stone formers and non-stone formers. BMC Nephrol . 2021 ;22 :204 . 34074247 10.1186/s12882-021-02417-8 PMC8170929
[23] Bushinsky DA . Dysregulation of the calcium, phosphorus, parathyroid hormone, and vitamin D axis: what are the causes and risks? Am J Kidney Dis . 2001 ;37 :1310Not reported2 . 11382706 10.1053/ajkd.2001.25519
[24] Civitelli R Ziambaras K . Calcium and phosphate homeostasis: concerted interplay of new regulators. J Endocrinol Invest . 2011 ;34 (7 Suppl ):3Not reported7 . 21985972
[25] Blaine J Chonchol M Levi M . Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol . 2015 ;10 :1257Not reported72 . 25287933 10.2215/CJN.09750913 PMC4491294
[26] Khan SR Canales BK Dominguez-Gutierrez PR . Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation. Nat Rev Nephrol . 2021 ;17 :417Not reported33 . 33514941 10.1038/s41581-020-00392-1
[27] Robertson WG . Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall’s plugs and calcium oxalate crystalluria in a computer model of renal function. Urolithiasis . 2015 ;43 (Suppl 1 ):93Not reported107 . 25407799 10.1007/s00240-014-0737-1
[28] Yang B Dissayabutra T Ungjaroenwathana W . Calcium oxalate crystallization index (COCI): an alternative method for distinguishing nephrolithiasis patients from healthy individuals. Ann Clin Lab Sci . 2014 ;44 :262Not reported71 . 25117095
[29] Kaneko I Saini RK Griffin KP Whitfield GK Haussler MR Jurutka PW . FGF23 gene regulation by 1,25-dihydroxyvitamin D: opposing effects in adipocytes and osteocytes. J Endocrinol . 2015 ;226 :155Not reported66 . 26148725 10.1530/JOE-15-0225 PMC4560246
[30] Nguyen-Yamamoto L Karaplis AC St-Arnaud R Goltzman D . Fibroblast growth factor 23 regulation by systemic and local osteoblast-synthesized 1,25-dihydroxyvitamin D. J Am Soc Nephrol . 2017 ;28 :586Not reported97 . 27535551 10.1681/ASN.2016010066 PMC5280015
[31] Allison SJ . Claudin 2: role in hypercalciuria and kidney stone disease. Nat Rev Nephrol . 2020 ;16 :252 . 10.1038/s41581-020-0273-x 32210380
[32] Vezzoli G Terranegra A Rainone F . Calcium-sensing receptor and calcium kidney stones. J Transl Med . 2011 ;9 :201 . 22107799 10.1186/1479-5876-9-201 PMC3339356
[33] Chou YH Woon PY Chen WC . A genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with stone multiplicity in calcium nephrolithiasis. PLoS One . 2011 ;6 :e25227 . 21966463 10.1371/journal.pone.0025227 PMC3178627
[34] Žofková I . Hypercalcemia. Pathophysiological aspects. Physiol Res . 2016 ;65 :1Not reported10 . 26596315 10.33549/physiolres.933059
[35] Sun Y Liu Y Guan X . Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF-κB and NLRP3 inflammasome. IUBMB Life . 2020 ;72 :1065Not reported74 . 32083808 10.1002/iub.2250
[36] Mulay SR Kulkarni OP Rupanagudi KV . Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. J Clin Invest . 2013 ;123 :236Not reported46 . 23221343 10.1172/JCI63679 PMC3533282
[37] Li Y Zhang J Liu H . Curcumin ameliorates glyoxylate-induced calcium oxalate deposition and renal injuries in mice. Phytomedicine . 2019 ;61 :152861 . 31029908 10.1016/j.phymed.2019.152861
[38] Sun Y Sun H Zhang Z . New insight into oxidative stress and inflammatory responses to kidney stones: potential therapeutic strategies with natural active ingredients. Biomed Pharmacother . 2024 ;179 :117333 . 39243436 10.1016/j.biopha.2024.117333
[39] Khan SR . Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res . 2012 ;40 :95Not reported112 . 22213019 10.1007/s00240-011-0448-9 PMC5683185
[40] Gyawali PR Joshi BR Gurung CK . Correlation of calcium, phosphorus, uric acid and magnesium level in serum and 24 hours urine of patients with urolithiasis. Kathmandu Univ Med J (KUMJ) . 2011 ;9 :54Not reported6 . 10.3126/kumj.v9i2.6289 22610870
[41] Ferraro PM Taylor EN Curhan GC . 24-hour urinary chemistries and kidney stone risk. Am J Kidney Dis . 2024 ;84 :164Not reported9 . 38583757 10.1053/j.ajkd.2024.02.010 PMC13170619
Publication and source details

Original title: Positive association between serum calcium-phosphorus ratio and kidney stone prevalence: Analysis of NHANES data (2007 to 2020)

Jian Qin; Xia Liu; Miao Yu

Medicine · 2026

* Correspondence: Miao Yu, Department of Basic Medicine, Sichuan Vocational College of Health and Rehabilitation, No. 3 Deming Road, Xiantan Community, Xianshi Town, Yantan District, Zigong 643000, Sichuan, China (e-mail: miaoyu0718@163.com).Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, Inc.2026https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Zigong Municipal Health and Science Research Project22yb079Jian QinZigong Key Science and Technology Plan Project2020ZC28Jian Qin

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:32:17.473118+00:00

DOI: 10.1097/md.0000000000048432 · PMC13124337